ONYX PHARMACEUTICALS INC: current_liabilities
| Value | {"amount": 131369000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2012-12-31) |
| Status | current |
| Entity | ONYX PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:49:48.184497+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/610d7496-db2d-4f3b-af8d-545f11fe65fc
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001047469-13-001966 · Open the official SEC filing →Retrieved: 2026-08-19T09:49:48.184497+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001012140/current-liabilities/2012-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/610d7496-db2d-4f3b-af8d-545f11fe65fc
History
- no predecessors — first report